Choroidal Blood Flow in Acute and Chronic Central Serous Chorioretinopathy
ConditionCentral Serous Chorioretinopathy
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-70
SponsorHelse Stavanger HF
About this trial
Patients with central serous chorioretinopathy (CSC) will be monitored with laser speckle flow graphy (LSFG), swept source optical coherence tomography (SS-OCT) and SS-OCT angiography (SS-OCTA). The aim is to unveil the flow and pulse wave characteristics of the choroidal circulation in acute CSC and chronic CSC.
Eligibility criteria
Qualifiers
Able to sign informed consent
Possible to obtain fundus imaging
Subfoveal presence of SRF on OCT
Present attack is 1st -3rd attack of CSC
Disqualifiers
History of retinal disease other than CSC (e.g. retinal detachment)
Contraindications for FA, ICGA or PDT (only for chronic CSC)
Trial design
Treatments tested in this trial
- Verteporfin
Treatment groups
50 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov